Regulation of Akt(ser473) phosphorylation by choline kinase in breast carcinoma cells

Boon Tin Chua1, David Gallego-Ortega, Ana Ramirez de Molina

  • 1Singapore OncoGenome Project, Institute of Medical Biology, A*STAR, 8A Biomedical Grove, 06-06 Immunos, Singapore. boontin.chua@imb.a-star.edu.sg

Molecular Cancer
|January 1, 2010
PubMed
Abstract

Insights

Choline kinase regulates Akt(ser473) phosphorylation, a key pathway in cell survival and proliferation. Inhibiting choline kinase significantly reduces tumor growth in mouse models, suggesting its therapeutic potential in cancer treatment.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Cell Signaling

Background:

  • The Akt pathway is crucial for cell growth, metabolism, and survival.
  • Mutations in Akt pathway components like PTEN and PI3-kinase are common in human cancers.
  • Understanding Akt activation regulation is vital for cancer therapy.

Purpose of the Study:

  • To identify kinases regulating Akt activation, specifically at serine 473.
  • To investigate the role of Choline kinase in Akt phosphorylation.
  • To evaluate the therapeutic potential of Choline kinase inhibitors in cancer models.

Main Methods:

  • Screening of a human kinome siRNA library in MDA-MB 468 breast cancer cells.
  • Measurement of Akt(ser473) phosphorylation using specific antibodies.
  • Inhibition of Choline kinase using siRNA and small molecule inhibitors.
  • Assessment of tumor growth and Akt phosphorylation in xenograft mouse models.

Main Results:

  • Over 90 kinases were identified as regulators of Akt(ser473) phosphorylation.
  • Choline kinase inhibition significantly reduced Akt(ser473) phosphorylation in a PI3K-independent manner.
  • Choline kinase inhibitors led to statistically significant tumor regression in xenograft models.
  • Reduced Akt phosphorylation correlated with decreased tumor size.

Conclusions:

  • Choline kinase plays a significant role in regulating Akt(ser473) phosphorylation.
  • This regulation by Choline kinase promotes cancer cell survival and proliferation.
  • Choline kinase inhibition represents a promising therapeutic strategy for targeting Akt-driven cancers.

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Protein Kinases and Phosphatases02:54

Protein Kinases and Phosphatases

Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Phosphorylation01:02

Phosphorylation

The addition or removal of phosphate groups from proteins is the most common chemical modification that regulates cellular processes. These modifications can affect the structure, activity, stability, and localization of proteins within cells as well as their interactions with other proteins.
During phosphorylation, protein kinases transfer the terminal phosphate group of ATP to specific amino acid side chains of substrate proteins. Serine, threonine, and tyrosine are the most commonly...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...